(October 14, 2019, 2:19 PM EDT) -- CLEVELAND — On the same day it was filed, the Ohio federal judge overseeing the opioid multidistrict litigation on Oct. 11 denied Teva Pharmaceuticals USA Inc.’s motion to sever it from the Oct. 21 bellwether trial because it won’t have enough time to differentiate between its subsidiaries and other nonmanufacturing defendants (In Re: National Prescription Opiate Litigation, MDL Docket No. 2804, No. 17-md-2804, N.D. Ohio)....